{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:34:00Z","timestamp":1777541640560,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11010-016-2890-z","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T21:13:45Z","timestamp":1479935625000},"page":"183-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of zofenopril on cardiac function and pro-oxidative parameters in the streptozotocin-induced diabetic rat heart"],"prefix":"10.1007","volume":"426","author":[{"given":"Petar","family":"Ristic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Srejovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidora","family":"Stojic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Ristic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Zivkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir Lj.","family":"Jakovljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"issue":"16","key":"2890_CR1","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinte.164.16.1737","volume":"164","author":"HS Lim","year":"2004","unstructured":"Lim HS, MacFadyen RJ, Lip GY (2004) Diabetes mellitus, the renin\u2013angiotensin\u2013aldosterone system and the heart. Arch Intern Med 164(16):1737\u20131748","journal-title":"Arch Intern Med"},{"issue":"12","key":"2890_CR2","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","volume":"57","author":"VP Singh","year":"2008","unstructured":"Singh VP, Le B, Khode R, Baker KM, Kumar R (2008) Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57(12):3297\u20133306","journal-title":"Diabetes"},{"issue":"5","key":"2890_CR3","doi-asserted-by":"crossref","first-page":"R510","DOI":"10.1152\/ajpregu.00512.2011","volume":"302","author":"R Kumar","year":"2012","unstructured":"Kumar R, Yong QC, Thomas CM, Baker KM (2012) Intracardiac intracellular angiotensin system in diabetes. Am J Physiol Regul Integr Comp Physiol 302(5):R510\u2013R517","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2890_CR4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12(3):144\u2013153","journal-title":"Nat Rev Endocrinol"},{"issue":"15","key":"2890_CR5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C, ONTARGET Investigators (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547\u20131559","journal-title":"N Engl J Med"},{"issue":"23","key":"2890_CR6","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA, ALTITUDE Investigators (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367(23):2204\u20132213","journal-title":"N Engl J Med"},{"issue":"20","key":"2890_CR7","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","volume":"369","author":"LF Fried","year":"2013","unstructured":"Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O\u2019Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P, VA, NEPHRON-D Investigators (2013) Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 369(20):1892\u20131903","journal-title":"N Engl J Med"},{"issue":"346","key":"2890_CR8","doi-asserted-by":"crossref","first-page":"f360","DOI":"10.1136\/bmj.f360","volume":"28","author":"H Makani","year":"2013","unstructured":"Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH (2013) Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomized trials. BMJ 28(346):f360","journal-title":"BMJ"},{"issue":"2","key":"2890_CR9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.HYP.0000025879.29822.24","volume":"40","author":"JC Barbato","year":"2002","unstructured":"Barbato JC, Mulrow PJ, Shapiro JI, Franco-Saenz R (2002) Rapid effects of aldosterone and spironolactone in the isolated working rat heart. Hypertension 40(2):130\u2013135","journal-title":"Hypertension"},{"issue":"1","key":"2890_CR10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1755-5922.2010.00205.x","volume":"30","author":"PJ Lijnen","year":"2012","unstructured":"Lijnen PJ, van Pelt JF, Fagard RH (2012) Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc Ther 30(1):e1\u2013e8","journal-title":"Cardiovasc Ther"},{"issue":"1\u20132","key":"2890_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11010-011-0766-9","volume":"352","author":"V Carnicelli","year":"2011","unstructured":"Carnicelli V, Frascarelli S, Zucchi R (2011) Effect of acute and chronic zofenopril administration on cardiac gene expression. Mol Cell Biochem 352(1\u20132):301\u2013307","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"2890_CR12","doi-asserted-by":"crossref","first-page":"H1137","DOI":"10.1152\/ajpheart.2001.281.3.H1137","volume":"281","author":"Y Zhong","year":"2001","unstructured":"Zhong Y, Ahmed S, Grupp IL, Matlib MA (2001) Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 281(3):H1137\u2013H1147","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"2890_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/B:MCBI.0000028762.97754.26","volume":"261","author":"Z Vasanji","year":"2004","unstructured":"Vasanji Z, Dhalla NS, Netticadan T (2004) Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Mol Cell Biochem 261(1\u20132):245\u2013249","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"2890_CR14","first-page":"115","volume":"17","author":"NS Dhalla","year":"2012","unstructured":"Dhalla NS, Rangi S, Zieroth S, Xu YJ (2012) Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy. Exp Clin Cardiol 17(3):115\u2013120","journal-title":"Exp Clin Cardiol"},{"issue":"2","key":"2890_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.1999.tb00008.x","volume":"17","author":"A Subissi","year":"1999","unstructured":"Subissi A, Evangelista S, Giachetti A (1999) Preclinical profile of zofenopril: an angiotensin converting enzyme inhibitor with peculiar cardioprotective properties. Cardiovasc Drug Rev 17(2):115\u2013133","journal-title":"Cardiovasc Drug Rev"},{"issue":"25","key":"2890_CR16","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115(25):3213\u20133223","journal-title":"Circulation"},{"issue":"38","key":"2890_CR17","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","volume":"36","author":"T M\u00fcnzel","year":"2015","unstructured":"M\u00fcnzel T, Gori T, Keaney JF Jr, Maack C, Daiber A (2015) Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J 36(38):2555\u20132564","journal-title":"Eur Heart J"},{"issue":"6","key":"2890_CR18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00005344-198906000-00011","volume":"13","author":"JM DeForrest","year":"1989","unstructured":"DeForrest JM, Waldron TL, Krapcho J, Turk C, Rubin B, Powell JR, Cushman DW, Petrillo EW (1989) Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme. J Cardiovasc Pharmacol 13(6):887\u2013894","journal-title":"J Cardiovasc Pharmacol"},{"key":"2890_CR19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","volume":"12","author":"GH Tesch","year":"2007","unstructured":"Tesch GH, Allen TJ (2007) Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology 12:261\u2013266","journal-title":"Nephrology"},{"key":"2890_CR20","first-page":"123","volume-title":"CRC handbook of methods for oxygen radical research","author":"C Auclair","year":"1985","unstructured":"Auclair C, Voisin E (1985) Nitroblue tetrazolium reduction. In: Greenwald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 123\u2013132"},{"key":"2890_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagnwr DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and (15\u00a0N) nitrate in biological fluids. Anal Biochem 126:131\u2013138","journal-title":"Anal Biochem"},{"key":"2890_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-1759(80)90340-3","volume":"38","author":"E Pick","year":"1980","unstructured":"Pick E, Keisari Y (1980) A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38:161\u2013170","journal-title":"J Immunol Methods"},{"key":"2890_CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"issue":"1","key":"2890_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707010-00002","volume":"7","author":"E Ambrosioni","year":"2007","unstructured":"Ambrosioni E (2007) Defining the role of zofenopril in the management of hypertension and ischemic heart disorders. Am J Cardiovasc Drugs 7(1):17\u201324","journal-title":"Am J Cardiovasc Drugs"},{"key":"2890_CR25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1464-5491.2003.01021.x","volume":"20","author":"Working Party of the International Diabetes Federation (European Region)","year":"2003","unstructured":"Working Party of the International Diabetes Federation (European Region) (2003) Hypertension in people with type 2 diabetes: knowledge-based diabetes-specific guidelines. Diabet Med 20:972\u2013987","journal-title":"Diabet Med"},{"issue":"6","key":"2890_CR26","first-page":"E528","volume":"244","author":"PK Ganguly","year":"1983","unstructured":"Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS (1983) Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244(6):E528\u2013E535","journal-title":"Am J Physiol"},{"issue":"1","key":"2890_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03165800","volume":"62","author":"XY Zhao","year":"2006","unstructured":"Zhao XY, Hu SJ, Li J, Mou Y, Chen BP, Xia Q (2006) Decreased cardiac sarcoplasmic reticulum Ca2+-ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats. J Physiol Biochem 62(1):1\u20138","journal-title":"J Physiol Biochem"},{"issue":"1","key":"2890_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02424571","volume":"107","author":"SW Schaffer","year":"1991","unstructured":"Schaffer SW (1991) Cardiomyopathy associated with noninsulin-dependent diabetes. Mol Cell Biochem 107(1):1\u201320","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"2890_CR29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0022-2828(81)90318-7","volume":"13","author":"S Penpargkul","year":"1981","unstructured":"Penpargkul S, Fein F, Sonnenblick EH, Scheuer J (1981) Depressed cardiac sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol 13(3):303\u2013309","journal-title":"J Mol Cell Cardiol"},{"issue":"1\u20132","key":"2890_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-006-9366-5","volume":"300","author":"FC Howarth","year":"2007","unstructured":"Howarth FC, Al-Sharhan R, Al-Hammadi A, Qureshi MA (2007) Effects of streptozotocin-induced diabetes on action potentials in the sinoatrial node compared with other regions of the rat heart. Mol Cell Biochem 300(1\u20132):39\u201346","journal-title":"Mol Cell Biochem"},{"key":"2890_CR31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0022-2828(78)90384-X","volume":"10","author":"NS Dhalla","year":"1978","unstructured":"Dhalla NS, Das PK, Sharma GP (1978) Subcellular basis of cardiaccontractile failure. J Mol Cell Cardiol 10:363\u2013385","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"2890_CR32","doi-asserted-by":"crossref","first-page":"H2144","DOI":"10.1152\/ajpheart.00591.2005","volume":"289","author":"PR Nagareddy","year":"2005","unstructured":"Nagareddy PR, Xia Z, McNeill JH, MacLeod KM (2005) Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289(5):H2144\u2013H2152","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"43","key":"2890_CR33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.niox.2014.08.004","volume":"1","author":"S Khanna","year":"2014","unstructured":"Khanna S, Singh GB, Khullar M (2014) Nitric oxide synthases and diabetic cardiomyopathy. Nitric Oxide 1(43):29\u201334","journal-title":"Nitric Oxide"},{"issue":"17","key":"2890_CR34","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.febslet.2008.06.039","volume":"582","author":"MB West","year":"2008","unstructured":"West MB, Ramana KV, Kaiserova K, Srivastava SK, Bhatnagar A (2008) l-Arginine prevents metabolic effects of high glucose in diabetic mice. FEBS Lett 582(17):2609\u20132614","journal-title":"FEBS Lett"},{"issue":"1","key":"2890_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","volume":"75","author":"GY Oudit","year":"2007","unstructured":"Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH, Tsushima RG, Scholey JW, Khokha R, Penninger JM (2007) Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75(1):29\u201339","journal-title":"Cardiovasc Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2890-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-016-2890-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2890-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T18:38:30Z","timestamp":1568572710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-016-2890-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1007\/s11010-016-2890-z","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]}}}